April 6, 2024 – Pillararenes

Residual pharmaceuticals (II). 2009 (in Korean). NIER, Incheon. 21. Korea Pharmaceutical Manufacturers Association

Chemexpress April 6, 2024 0 Comments

Residual pharmaceuticals (II). 2009 (in Korean). NIER, Incheon. 21. Korea Pharmaceutical Companies Association (KPMA). Pharmaceutical production in 2009. 2010 (in Korean). KPMA, Seoul. 22. Korea Pharmaceutical Details Center. Monograph. Readily…

Uncategorized

Sufferers who exhibited much less than 40 platelet inhibition (P2Y12 ADP receptor

Chemexpress April 6, 2024 0 Comments

Sufferers who exhibited much less than 40 platelet inhibition (P2Y12 ADP receptor inhibition) on clopidogrel, as determined by platelet screening analysis (VerifyNow, Accumetrics, San Diego, California, USA), were loaded with…

Residual pharmaceuticals (II). 2009 (in Korean). NIER, Incheon. 21. Korea Pharmaceutical Manufacturers Association

Sufferers who exhibited much less than 40 platelet inhibition (P2Y12 ADP receptor

You Missed

2-chloro-N-5-[(dimethylamino)sulfonyl]-2-methoxyphenylacetamide (CAS 749906-93-2)

2-chloro-N-(9,10-dioxo-9,10-dihydroanthracen-2-yl)propanamide

1,2-Dipalmitoyl-sn-glycero-3-phosphate calcium salt (CAS 71640-91-0)

2-chloro-N-(4-chloro-1,1-dioxidotetrahydrothien-3-yl)acetamide